ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2016 American Transplant Congress

    An Improved Method for the Evaluation of Microvascular Inflammation in Renal Allograft Biopsies.

    M. Rooney,1 Z. Ping,2 D. Samarapungavan,3 R. Hennigar.4

    1Incyte Diagnostics, Spokane Valley, WA; 2Pathology, Beaumont Hospitals, Royal Oak, MI; 3Nephrology, Beaumont Hospitals, Royal Oak, MI; 4Nephropathology Associates, Little Rock, AR.

    Background: Microvascular inflammation (MVI), assessed as glomerulitis (g) + peritubular capillaritis (ptc), is associated with T cell mediated (CMR) and antibody mediated (AMR) allograft rejection.…
  • 2016 American Transplant Congress

    Antibody Mediated Rejection and Mixed Acute Rejection: Long Term Results and Predictive Factors for Graft Loss Following Proteasome Inhibitor Therapy.

    A. Lichvar,1 A. Leino,1 S. Tremblay,1 B. Abu-Jawdeh,1 A. Govil,1 G. Mogilishetty,1 M. Cardi,2 J. Kremer,2 M. Cuffy,1,2 F. Paterno,1 A. Shields,1,2 D. Witte,1 R. Alloway,1 E. Woodle.1

    1U of Cincinnati, Cincinnati; 2The Christ Hospital, Cincinnati.

    Purpose: Proteasome inhibitor (PI) therapy has been increasingly used to treated antibody mediated rejection (AMR) and mixed acute rejection (MAR). The purpose of this study…
  • 2016 American Transplant Congress

    A Non-Invasive Blood Transcriptional Assay, Ksort, Monitors Alloimmune Response in the Sailor Randomized Multicenter Trial.

    J. Ekberg,1 B. Jespersen,2 K. Skov,2 M. Sarwal,3 T. Sigdel,3 S. Hsieh,3 P. Lindner.1

    1Transplantation, Sahlgrenska University Hospital, Gothenburg, Sweden; 2Nephrology, Skejby Hospital, Aarhus, Denmark; 3Surgery, University of California, San Francisco.

    Non-invasive diagnosis and prediction of acute rejection (AR) is a critical unmet need. A In a randomized multicenter trial of 222 renal transplant recipients a…
  • 2016 American Transplant Congress

    Financial Cost of Cold Ischemia Time in Kidney Transplantation.

    O. Serrano,1 D. Vock,2 W. Payne,1 T. Dunn,1 S. Chinnakotla,1 R. Kandaswamy,1 T. Pruett,1 A. Matas,1 R. Feldman,3 E. Finger.1

    1Surgery, Univ. of Minnesota, Minneapolis, MN; 2Biostatistics, University of Minnesota, Minneapolis, MN; 3Health Policy & Management, Univ. of Minnesota, Minneapolis, MN.

    PURPOSE: A new kidney allocation system (KAS) was implemented in December 2014 using the kidney donor profile index (KDPI), which prioritizes historically-disadvantaged populations. While KAS…
  • 2016 American Transplant Congress

    Lessons Learned Transplanting High KDPI Kidneys Over a Decade: Improvements in Graft Survival Stem from Lower Rates of Early Graft Loss.

    S. Sanoff,1 K. Ravindra, D. Vikraman, U. Patel, D. Sudan, W. Irish.2

    1Duke University Medical Center, Durham, NC; 2CTI Clinical Trial and Consulting Services, Raleigh, NC.

    Purpose. The Kidney Donor Profile Index (KDPI) recently replaced SCD/ECD designations, to provide transplant centers a more precise estimate of predicted graft survival, with the…
  • 2016 American Transplant Congress

    Angiotensin II Type-1 Receptor Antibodies in Renal Transplant Recipients Associated with Ventricular and Endothelial Dysfunction: Preliminary Results.

    L. Figuerola-Chaparro,1 F. Davila-Radilla,1 E. Cuevas,2 L. Castillo-Martínez,1 A. Orea-Tejeda,1 J. Arreola-Guerra,2 J. Alberu.2

    1Cardiology, Inst Nal Ciencias Medicas y Nutricion SZ, Mexico City, Mexico; 2Transplantation, Inst Nal Ciencias Medicas y Nutricion SZ, Mexico City, Mexico.

    Previous studies demonstrated the significance of angiotensin II type-1 receptor antibodies (AT1Rabs) in processes including hypertension, cardiac hypertrophy and renal fibrosis; information regarding ventricular and…
  • 2016 American Transplant Congress

    Role of TGF-β in Ischemia and Reperfusion Injury Induced Renal Fibrosis in Human Proximal Tubular Epithelial Cells.

    R. Kapoor, N. Sheerin, J. Kirby.

    Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom.

    Ischemia-reperfusion injury (IRI) leads to an irreversible damage to the tubular epithelium and promotes acute kidney injury (AKI) that is associated with progressive loss of…
  • 2016 American Transplant Congress

    Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo.

    K. Bonner, N. Moore, M. Moreno Gonzales, M. Stegall.

    Department of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, MN.

    Introduction:Plasma cells (PCs) are a major source of alloantibody in transplant patients.They are resistant to current therapy. Since receptor/ligand interactions in the stromal environment are…
  • 2016 American Transplant Congress

    End-Stage Renal Disease Does Not Impair the Large-Scale Generation of Potent Alloantigen-Specific Regulatory T Cells for Immunotherapy.

    N. Litjens, K. Boer, J. Zuijderwijk, M. Klepper, A. Peeters, W. Verschoor, R. Kraaijeveld, C. Baan, M. Betjes.

    Internal Medicine, Nephrology and Transplantation, Erasmus University Medical Centre, Rotterdam, Netherlands.

    Background Alloantigen-specific natural occurring regulatory T cells (nTregs) have the potential to offer a more targeted approach of immunosuppression and are the cell type of…
  • 2016 American Transplant Congress

    The Role and Mechanism of CD40/CD40L Expression on Different T-Cell Subsets.

    N. Granofszky, K. Hock, B. Mahr, N. Pilat-Michalek, T. Wekerle.

    Department of Surgery, Section of Transplantation Immunology, Medical University of Vienna, Vienna, Austria.

    Background: Several T-cell costimulatory pathways (i.e. CD28:B7 and CD40:CD40L) play a critical role in modulating alloreactivity, but their function on distinct T cell subsets remains…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences